Gil Roth12.09.13
Phase II
Cyclacel posts MDS trial results . . . read more
Emergent gets positive results in CLL trial . . . read more
QLT doses first IDA patient . . . read more
Phase III
Merck Serono publishes data for NSCLC trial . . . read more
Filings
Helsinn, Eisai CINV treatment to be reviewed . . . read more
Approvals
Gilead's HCV treatment approved . . . read more
Health Canada approves Novartis meningitis vaccine . . . read more
Post-Approval
Five-year data support Novartis' Tasigna in CML . . . read more
Cyclacel posts MDS trial results . . . read more
Emergent gets positive results in CLL trial . . . read more
QLT doses first IDA patient . . . read more
Phase III
Merck Serono publishes data for NSCLC trial . . . read more
Filings
Helsinn, Eisai CINV treatment to be reviewed . . . read more
Approvals
Gilead's HCV treatment approved . . . read more
Health Canada approves Novartis meningitis vaccine . . . read more
Post-Approval
Five-year data support Novartis' Tasigna in CML . . . read more